The FDA has selected IBM (NYSE:IBM), KPMG International, Merck (NYSE:MRK) and Walmart (NYSE:WMT) for a program to support the U.S. Drug Supply Chain Security Act (DSCSA).
The aim is to develop an electronic interoperable blockchain system enabling the real-time monitoring of products for drug supply chain stakeholders.
The pilot should be completed in Q4. The results will be published in the FDA DSCSA program report. Next steps will be evaluated at that time.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.